ArticleCellular oncology (Dordrecht, Netherlands)2026
Pharmacological inhibition of PGK1 suppresses EGFR-positive esophageal squamous cell carcinoma by dual targeting of glycolysis and autophagy-dependent EGFR degradation.
Juan Ge et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.